Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Jason Conaty
ID:
1b8328f7-2619-30fb-68c4
/
Unclaimed
/
Organization:
Hogan Lovells
Published Works
4 articles
FDA to consider patent listing, therapeutic equivalence, and other Orange Book issues; agency will issue draft guidance documents, seek public comment
Focus on Regulation ·
February 4, 2019
cite
New Rule Amends FDA’s Citizen Petition Regulations to Implement Section 505(q) of the Food, Drug, and Cosmetic Act
Focus on Regulation ·
December 4, 2016
cite
D.C. Circuit Issues Landmark Ruling for Stem Cell Therapies
Focus on Regulation ·
February 5, 2014
cite
FDA Denies 5-Year Exclusivity to “Stable Esters” and Confirms Structure-Based Approach to Exclusivity
Focus on Regulation ·
October 1, 2012
cite
